(Q40483599)

20 September 2017

1 reference

title

Review of adjuvant chemotherapy for gastric cancer (English)

1 reference

20 September 2017

T. Nakajima

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7676702

9 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7676702

9 August 2024

publication date

1 July 1995

1 reference

full work available at URL

20 September 2017

http://link.springer.com/content/pdf/10.1007/BF00294725.pdf

1 reference

https://api.crossref.org/works/10.1007/BF00294725

http://link.springer.com/article/10.1007/BF00294725/fulltext.html

9 August 2024

1 reference

https://api.crossref.org/works/10.1007/BF00294725

https://onlinelibrary.wiley.com/doi/pdf/10.1007/BF00294725

9 August 2024

1 reference

https://api.crossref.org/works/10.1007/BF00294725

9 August 2024

published in

World Journal of Surgery

1 reference

20 September 2017

volume

19

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

570-574

1 reference

[The role of thymidylate synthetase in sequential dose of MTX and 5-FU in the advanced scirrhous type gastric cancer]

20 September 2017

cites work

1 reference

12 December 2020

Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5-fluorouracil

1 reference

12 December 2020

Treatment with 5-fluorouracil in prophylaxis of relapses and metastases of stomach cancer

1 reference

12 December 2020

A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group

1 reference

12 December 2020

The use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of gastric carcinoma

1 reference

12 December 2020

A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer

1 reference

12 December 2020

Long-term follow-up study of gastric cancer patients treated with surgery and adjuvant chemotherapy with mitomycin C

1 reference

12 December 2020

5-fluorouracil, adriamycin, and mitomycin-c (fam) combination chemotherapy in the treatment of advanced gastric cancer

1 reference

12 December 2020

Gastric carcinoma treated by chemotherapy after resection: a controlled study

1 reference

12 December 2020

Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275).

1 reference

12 December 2020

Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence of gastric cancer

1 reference

12 December 2020

Adjuvant chemotherapy for gastric cancer in Japan: present status and suggestions for rational clinical trials

1 reference

12 December 2020

Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer

1 reference

12 December 2020

Mitomycin C as an adjuvant in resected gastric cancer

1 reference

12 December 2020

Adjuvant FAM2 in resectable gastric cancer

1 reference

12 December 2020

Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A veterans administration surgical oncology group report

1 reference

12 December 2020

Rseults of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence.

1 reference

12 December 2020

The rationale behind intraperitoneal chemotherapy in gastrointestinal malignancies

1 reference

12 December 2020

[Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide]

1 reference

12 December 2020

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer

1 reference

12 December 2020

Phase II trial of fluorouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology Group study

1 reference

12 December 2020

A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.

1 reference

12 December 2020

Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials

1 reference

12 December 2020

Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer

1 reference

12 December 2020

Use of 5-fluorodeoxyuridine (FUDR) as an adjuvant to the surgical management of carcinoma of the stomach.

1 reference

12 December 2020

Advanced gastric cancer: a new combined surgical and oncological approach

1 reference

12 December 2020

Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C

1 reference

12 December 2020

Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in man

1 reference

12 December 2020

Five-year survival rate of gastric cancer patients treated by gastrectomy, large dose of mitomycin-C, and-or allogeneic bone marrow transplantation

1 reference

12 December 2020

An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British stomach cancer group

1 reference

12 December 2020

Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation

1 reference

12 December 2020

Use of Triethylenethiophosphoramide as an Adjuvant to the Surgical Treatment of Gastric and Colorectal Carcinoma

1 reference

12 December 2020

Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00294725

1 reference

Dimensions Publication ID

20 September 2017

1049734561

0 references

1 reference